Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Interest Expenses came in at $725.5 million in Q1 2026, up 4324.08% year-on-year from $16.4 million in Q1 2025, and up 3052.5% quarter-over-quarter from $23.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $725.5 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 4324.08% year-over-year to $725.5 million in Q1 2026; TTM through Mar 2026 was $725.5 million, a 2546.83% increase from a year earlier, with the FY2025 full-year figure at $51.3 million, up 13.32% from the prior year.
- Interest Expenses grew to $725.5 million in Q1 2026 per AAWH's latest filing, from $23.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $725.5 million in Q1 2026 and bottomed at -$14.0 million in Q4 2024.
- The 5-year median for Interest Expenses is $9.4 million (2022), against an average of $87.1 million.
- Across the five-year window, Interest Expenses tumbled 257.38% in 2024 and surged 7053.85% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $9.4 million in 2022, then decreased by 5.83% to $8.9 million in 2023, then tumbled by 257.38% to -$14.0 million in 2024, then jumped by 264.35% to $23.0 million in 2025, then surged by 3052.5% to $725.5 million in 2026.
- Per Business Quant, the three latest AAWH Interest Expenses figures stand at $725.5 million (Q1 2026), $23.0 million (Q4 2025), and $12.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 725.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725.55 Mn |
| Mar 31, 2026 | 725.55 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Jun 30, 2025 | 610.58 Mn |
| Jun 30, 2025 | 610.58 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Dec 31, 2024 | -14.00 Mn |
| Dec 31, 2024 | -14.00 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | 8.90 Mn |
| Dec 31, 2023 | 8.90 Mn |